244 related articles for article (PubMed ID: 26098886)
21. Functional Characterization of Transient Receptor Potential (TRP) Channel C5 in Female Murine Gonadotropes.
Beck A; Götz V; Qiao S; Weissgerber P; Flockerzi V; Freichel M; Boehm U
Endocrinology; 2017 Apr; 158(4):887-902. PubMed ID: 28324107
[TBL] [Abstract][Full Text] [Related]
22. Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma.
Batova A; Altomare D; Creek KE; Naviaux RK; Wang L; Li K; Green E; Williams R; Naviaux JC; Diccianni M; Yu AL
PLoS One; 2017; 12(3):e0172632. PubMed ID: 28296891
[TBL] [Abstract][Full Text] [Related]
23. An ex vivo perfused ventilated murine lung model suggests lack of acute pulmonary toxicity of the potential novel anticancer agent (-)-englerin A.
Schremmer C; Steinritz D; Gudermann T; Beech DJ; Dietrich A
Arch Toxicol; 2022 Apr; 96(4):1055-1063. PubMed ID: 35165752
[TBL] [Abstract][Full Text] [Related]
24. TRPC channels and their splice variants are essential for promoting human ovarian cancer cell proliferation and tumorigenesis.
Zeng B; Yuan C; Yang X; Atkin SL; Xu SZ
Curr Cancer Drug Targets; 2013 Jan; 13(1):103-16. PubMed ID: 22920441
[TBL] [Abstract][Full Text] [Related]
25. A benzothiadiazine derivative and methylprednisolone are novel and selective activators of transient receptor potential canonical 5 (TRPC5) channels.
Beckmann H; Richter J; Hill K; Urban N; Lemoine H; Schaefer M
Cell Calcium; 2017 Sep; 66():10-18. PubMed ID: 28807145
[TBL] [Abstract][Full Text] [Related]
26. TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A.
Cheung SY; Henrot M; Al-Saad M; Baumann M; Muller H; Unger A; Rubaiy HN; Mathar I; Dinkel K; Nussbaumer P; Klebl B; Freichel M; Rode B; Trainor S; Clapcote SJ; Christmann M; Waldmann H; Abbas SK; Beech DJ; Vasudev NS
Oncotarget; 2018 Jul; 9(51):29634-29643. PubMed ID: 30038709
[TBL] [Abstract][Full Text] [Related]
27. Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice.
Just S; Chenard BL; Ceci A; Strassmaier T; Chong JA; Blair NT; Gallaschun RJ; Del Camino D; Cantin S; D'Amours M; Eickmeier C; Fanger CM; Hecker C; Hessler DP; Hengerer B; Kroker KS; Malekiani S; Mihalek R; McLaughlin J; Rast G; Witek J; Sauer A; Pryce CR; Moran MM
PLoS One; 2018; 13(1):e0191225. PubMed ID: 29385160
[TBL] [Abstract][Full Text] [Related]
28. Suppression of transient receptor potential canonical channel 4 inhibits vascular endothelial growth factor-induced retinal neovascularization.
Song HB; Jun HO; Kim JH; Fruttiger M; Kim JH
Cell Calcium; 2015 Feb; 57(2):101-8. PubMed ID: 25605522
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of a stable and orally bioavailable englerin analogue.
Fash DM; Peer CJ; Li Z; Talisman IJ; Hayavi S; Sulzmaier FJ; Ramos JW; Sourbier C; Neckers L; Figg WD; Beutler JA; Chain WJ
Bioorg Med Chem Lett; 2016 Jun; 26(11):2641-4. PubMed ID: 27107948
[TBL] [Abstract][Full Text] [Related]
30. Transient Receptor Potential Canonical 4 and 5 Channel Antagonist ML204 Depolarized Pacemaker Potentials of Interstitial Cells of Cajal.
Lee JH; Wu WH; Huang XY; Jun JY; Choi S
J Neurogastroenterol Motil; 2020 Sep; 26(4):521-528. PubMed ID: 32321198
[TBL] [Abstract][Full Text] [Related]
31. Riluzole activates TRPC5 channels independently of PLC activity.
Richter JM; Schaefer M; Hill K
Br J Pharmacol; 2014 Jan; 171(1):158-70. PubMed ID: 24117252
[TBL] [Abstract][Full Text] [Related]
32. Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain.
Fowler MA; Sidiropoulou K; Ozkan ED; Phillips CW; Cooper DC
PLoS One; 2007 Jun; 2(6):e573. PubMed ID: 17593972
[TBL] [Abstract][Full Text] [Related]
33. Involvement of TRPC4 and 5 Channels in Persistent Firing in Hippocampal CA1 Pyramidal Cells.
Arboit A; Reboreda A; Yoshida M
Cells; 2020 Feb; 9(2):. PubMed ID: 32033274
[TBL] [Abstract][Full Text] [Related]
34. Differential PI(4,5)P
Ko J; Myeong J; Shin YC; So I
Sci Rep; 2019 Feb; 9(1):1849. PubMed ID: 30755645
[TBL] [Abstract][Full Text] [Related]
35. The specific activation of TRPC4 by Gi protein subtype.
Jeon JP; Lee KP; Park EJ; Sung TS; Kim BJ; Jeon JH; So I
Biochem Biophys Res Commun; 2008 Dec; 377(2):538-543. PubMed ID: 18854172
[TBL] [Abstract][Full Text] [Related]
36. Activation of TRPC4β by Gαi subunit increases Ca2+ selectivity and controls neurite morphogenesis in cultured hippocampal neuron.
Jeon JP; Roh SE; Wie J; Kim J; Kim H; Lee KP; Yang D; Jeon JH; Cho NH; Kim IG; Kang DE; Kim HJ; So I
Cell Calcium; 2013 Oct; 54(4):307-19. PubMed ID: 24011658
[TBL] [Abstract][Full Text] [Related]
37. Englerin A, a selective inhibitor of renal cancer cell growth, from Phyllanthus engleri.
Ratnayake R; Covell D; Ransom TT; Gustafson KR; Beutler JA
Org Lett; 2009 Jan; 11(1):57-60. PubMed ID: 19061394
[TBL] [Abstract][Full Text] [Related]
38. Critical roles of Gi/o proteins and phospholipase C-δ1 in the activation of receptor-operated TRPC4 channels.
Thakur DP; Tian JB; Jeon J; Xiong J; Huang Y; Flockerzi V; Zhu MX
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):1092-7. PubMed ID: 26755577
[TBL] [Abstract][Full Text] [Related]
39. Conserved gating elements in TRPC4 and TRPC5 channels.
Beck A; Speicher T; Stoerger C; Sell T; Dettmer V; Jusoh SA; Abdulmughni A; Cavalié A; Philipp SE; Zhu MX; Helms V; Wissenbach U; Flockerzi V
J Biol Chem; 2013 Jul; 288(27):19471-83. PubMed ID: 23677990
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
